LILLY-B4Z-MC-LYDO

Study Sponsor: Lilly

Study Title

Maintenance of Response After Open-Label Treatment With Atomoxetine Hydrochloride in Adult Outpatients With Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Controlled, Randomized Withdrawal Study

Medicine or Vaccine (generic name)

Atomoxetine

Sponsor Identification Number

B4Z-MC-LYDO

Trial Registry Identification Number(#'s)

NCT00700427

Medical Condition

Attention Deficit Hyperactivity Disorder

Phase

Phase 3

Link to study details on the Lilly Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/ct2/show/NCT00700427?term=B4Z-MC-LYDO&rank=1

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The annotated case report form is not available. A blank case report form will be provided.

Date Added to this Site

November 2014